Literature DB >> 18421060

Trastuzumab-related cardiotoxicity in the herceptin adjuvant trial.

Filippo Montemurro, Stefania Redana, Giorgio Valabrega, Rossella Martinello, Massimo Aglietta, Renato Palmiero.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18421060     DOI： 10.1200/JCO.2007.15.5044

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  5 in total

Review 1.  Role of trastuzumab in the management of HER2-positive metastatic breast cancer.

Authors:  Andrea Milani; Filippo Montemurro; Luisa Gioeni; Massimo Aglietta; Giorgio Valabrega
Journal:  Breast Cancer (Dove Med Press)       Date:  2010-11-24

2.  Cardiotoxicity with adjuvant trastuzumab use in breast cancer: A single institution's experience.

Authors:  Abdurrahman Aldiab
Journal:  J Saudi Heart Assoc       Date:  2010-05-11

Review 3.  [Internal medical therapy of gastrointestinal stroma tumors].

Authors:  P Reichardt
Journal:  Radiologe       Date:  2009-12       Impact factor: 0.635

4.  Cardiac safety of the adjuvant Trastuzumab in a Moroccan population: observational monocentric study of about 100 patients.

Authors:  Meryem Aitelhaj; Siham Lkhouyaali; Ghizlane Rais; Amina Mohtaram; Soundouss Raissouni; Brahim Ghissassi; Saber Boutayeb; Hind Mrabti; Youssef Bensouda; Hassan Errihani
Journal:  BMC Res Notes       Date:  2013-08-28

5.  Whole exome sequencing to identify genetic markers for trastuzumab-induced cardiotoxicity.

Authors:  Chihiro Udagawa; Hiromi Nakamura; Hiroshi Ohnishi; Kenji Tamura; Tatsunori Shimoi; Masayuki Yoshida; Teruhiko Yoshida; Yasushi Totoki; Tatsuhiro Shibata; Hitoshi Zembutsu
Journal:  Cancer Sci       Date:  2018-01-24       Impact factor: 6.716
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.